← Back
Data updated: Mar 10, 2026
UDL
Pharmaceuticals
UDL is a generic drug manufacturer with 4 FDA-approved products.
1983
Since
4
Drugs
-
Trials
69
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
MECLIZINE HYDROCHLORIDE 2026-01-06
Labeling
PREDNISONE 2025-10-01
FOLIC ACID 2025-08-13
Labeling
PREDNISOLONE 2025-06-23
PREDNISOLONE 2025-02-13
Manufacturing (CMC)
PREDNISOLONE 2024-07-22
Labeling
PREDNISONE 2024-06-07
Labeling
PREDNISONE 2024-06-07
Labeling
PREDNISONE 2024-06-07
Labeling
PREDNISONE 2024-06-07
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (4)
Company Info
- First Approval
- 1983-03-29
- Latest
- 1983-03-29
- Applications
- 7